Catalyst Wire Dossier Catalyst Wire Dossier

Meningococcal polysaccharide diphtheria toxoid conjugate vaccine (serogroups A, C, Y, W-135)

Meningococcal polysaccharide diphtheria toxoid conjugate vaccine · JN-International Medical Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meningococcal polysaccharide diphtheria toxoid conjugate vaccine (serogroups A, C, Y, W-135), covering 2013-01-14 to 2013-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis [Phase 1]

See pricing